Abstract
SEVERAL inflammatory diseases, including asthma, arthritis and psoriasis are associated with the production of leukotrienes by neutrophils, mast cells and macrophages1–3. The initial enzymatic step in the formation of leukotrienes is the oxidation of arachidonic acid by 5-lipoxygenase (5-LO) to leukotriene A4 (refs 4–6). Osteosarcoma cells transfected with 5-LO express active enzyme in broken cell preparations, but no leukotriene metabolites are produced by these cells when stimulated with the calcium ionophore A23187, indicating that an additional component is necessary for cellular 5-LO activity7. A new class of indole leukotriene inhibitor has been described that inhibits the formation of cellular leukotrienes but has no direct inhibitory effect on soluble 5-LO activity8. We have now used these potent agents to identify and isolate a novel membrane protein of relative molecular mass 18,000 which is necessary for cellular leukotriene synthesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Samuelsson, B. Science 220, 568–575 (1983).
Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A. & Serhan, C. N. Science 237, 1171–1176 (1987).
Rokach, J. Leukotrienes and Lipoxygenases (Elsevier, Amsterdam, 1989).
Shimizu, T., Radmark, O. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 81, 689–693 (1984).
Shimizu, T. et al. Proc. natn. Acad. Sci. U.S.A. 83, 4175–4179 (1986).
Rouzer, C. A., Matsumoto, T. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 83, 857–861 (1986).
Rouzer, C. A. et al. J. biol. Chem. 263, 10135–10140 (1988).
Gillard, J. et al. Can. J. Physiol. Pharmac. 67, 456–464 (1989).
Rouzer, C. A. J. biol. Chem. (in the press).
Rouzer, C. A. & Kargman, S. J. biol. Chem. 263, 10980–10988 (1988).
Kuehl, F. A. Jr., Dougherty, H. W. & Ham, E. A. Biochem. Pharmac. 33, 1–5 (1984).
Chilton, F. H. Biochem. J. 258, 327–333 (1989).
Ham, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 80, 4349–4353 (1983).
Boyum, A. Scand. J. clin. Lab. Invest. (suppl. 97) 21, 77–89 (1968).
Guindon, Y. et al. in Advances in Prostaglandin, Thromboxane and Leukotriene Research (eds Samuelsson, B., Paoletti, R. & Ramwell, P. W.) 554–557 (Raven, New York, 1987).
Gan, Z. R. Gene 79, 159–166 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, D., Gillard, J., Vickers, P. et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343, 278–281 (1990). https://doi.org/10.1038/343278a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/343278a0
- Springer Nature Limited
This article is cited by
-
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology
Molecular Neurobiology (2023)
-
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase
Scientific Reports (2017)
-
FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo
Translational Psychiatry (2013)
-
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
Journal of Neuroinflammation (2012)
-
Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention
Current Colorectal Cancer Reports (2012)